Apologies for starting a new thread.
However in researching this company with a view to invest tomorrow I note that BD1 published results on ovarian cancer on 9th January this year that look to me to be better than today's published results. These ovarian cancer results are also referred to in today's announcement. However the BD1 share price has remained below 2 cents for virtually all of 2018.
The SP jumped today, but hardly moved based on excellent results that have been out there in the public domain for the past ten months! Can anybody enlighten me on why BD1 was unloved from January to now? And please do not refer to the BIT effect. BD1's January results should have been a reason for SP excitement in their own right.
Apologies for starting a new thread. However in researching this...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
0.005(0.85%) |
Mkt cap ! $65.61M | |||
| Open | High | Low | Value | Volume |
| 59.5¢ | 59.5¢ | 59.5¢ | $3.71K | 6.235K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3765 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 8174 | 2 |
View Market Depth
| Last trade - 11.03am 29/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |